Minghui Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Minghui Chen has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Guohui Cheng
School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China
4 shared publications - Jingui Qian
Anhui Province Key Laboratory of Measuring Theory and Precision Instrument, School of Instrument Science and Opto-Electronics Engineering, Hefei University of Technology, Hefei, China
4 shared publications - Shaohui Zheng
School of Medical Imaging, Xuzhou Medical University, Xuzhou 221006, China
4 shared publications - Liang Huang
Hefei University of Technology
3 shared publications Chuanmin Liu
Anhui Province Key Laboratory of Measuring Theory and Precision Instrument School of Instrument Science and Opto‐Electronics Engineering Hefei University of Technology Hefei China
2 shared publicationsHanbo Xu
School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, PR China
2 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (20)
Rapid Detection of Klebsiella pneumoniae in Infants With Severe Infection Disease by Instant Nanofluorescent Microspheres‐Immunochromatography Combined With Recombinase Polymerase Isothermal Amplification Technology
Background: Klebsiella pneumoniae (KP) is an important and virulent pathogen causing acute respiratory infections in infants. Currently, traditional methods for detecting Klebsiella pneumoniae in babies are labour‐intensive and time‐consuming, and their accuracy and sensitivity require improvement. Recombinant enzyme polymerase amplification technology (RPA) has the advantages of good specificity, high sensitivity, and isothermal amplification. It can be combined with fluorescence immunochromatography test strip (FICTS) based on nanofluorescent microspheres (nFM) to achieve rapid, low‐cost, high sensitivity, and specific detection of Klebsiella pneumoniae in infants. Methods: mdh was selected as a genus‐specific gene from Klebsiella pneumoniae , and recombinant polymerase isothermal amplification—nanofluorescence microsphere immunochromatography (RPA‐FICTS) was established by using standard strains. The sensitivity and specificity of this detection technology can be improved by the magnetic bead purification step of RPA nucleic acid amplification products. Subsequently, rapid quantitative detection of K. pneumoniae in infant samples was performed using fluorescent immunochromatographic test strips. A total of 19 clinical samples of Klebsiella pneumoniae (KP) and 7 clinical samples of non‐ Klebsiella pneumoniae (nKP) were detected by the new detection technology platform established in this paper, and the specificity and sensitivity of RPA‐FICTS were verified by agarose gel electrophoresis. Results: Under the optimal detection conditions, the maximum detection limits of RPA‐GE (agarose gel electrophoresis) and RPA‐FICTS are 9.03 × 10 −3 and 9.03 × 10 −8 ng/μL. RPA‐FICTS can quickly detect Klebsiella pneumoniae and specifically distinguish between Klebsiella pneumoniae and non‐ Klebsiella pneumoniae . Compared with traditional detection methods, this method has a shorter detection time (55 min), strong specificity, high sensitivity, and simple operation, providing a new method for rapid detection of human Klebsiella pneumoniae .
- 8 October 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (20)
Open AccessRapid Detection of Klebsiella pneumoniae in Infants With Severe Infection Disease by Instant Nanofluorescent Microspheres‐Immunochromatography Combined With Recombinase Polymerase Isothermal Amplification Technology
Background: Klebsiella pneumoniae (KP) is an important and virulent pathogen causing acute respiratory infections in infants. Currently, traditional methods for detecting Klebsiella pneumoniae in babies are labour‐intensive and time‐consuming, and their accuracy and sensitivity require improvement. Recombinant enzyme polymerase amplification technology (RPA) has the advantages of good specificity, high sensitivity, and isothermal amplification. It can be combined with fluorescence immunochromatography test strip (FICTS) based on nanofluorescent microspheres (nFM) to achieve rapid, low‐cost, high sensitivity, and specific detection of Klebsiella pneumoniae in infants. Methods: mdh was selected as a genus‐specific gene from Klebsiella pneumoniae , and recombinant polymerase isothermal amplification—nanofluorescence microsphere immunochromatography (RPA‐FICTS) was established by using standard strains. The sensitivity and specificity of this detection technology can be improved by the magnetic bead purification step of RPA nucleic acid amplification products. Subsequently, rapid quantitative detection of K. pneumoniae in infant samples was performed using fluorescent immunochromatographic test strips. A total of 19 clinical samples of Klebsiella pneumoniae (KP) and 7 clinical samples of non‐ Klebsiella pneumoniae (nKP) were detected by the new detection technology platform established in this paper, and the specificity and sensitivity of RPA‐FICTS were verified by agarose gel electrophoresis. Results: Under the optimal detection conditions, the maximum detection limits of RPA‐GE (agarose gel electrophoresis) and RPA‐FICTS are 9.03 × 10 −3 and 9.03 × 10 −8 ng/μL. RPA‐FICTS can quickly detect Klebsiella pneumoniae and specifically distinguish between Klebsiella pneumoniae and non‐ Klebsiella pneumoniae . Compared with traditional detection methods, this method has a shorter detection time (55 min), strong specificity, high sensitivity, and simple operation, providing a new method for rapid detection of human Klebsiella pneumoniae .
Monolithic Acoustic Droplet Centrifuge Array for Enhancing Point‐of‐Care Detection of Trace MicroRNAs
MicroRNAs (miRNAs) are considered as critical biomarkers for early tumor diagnosis, yet conventional detection methods are limited in sample throughput, sensitivity, automation, and broader applicability. A promising approach for achieving a point‐of‐care detection platform involves the integration of physical pretreatment and biological sensing within a single microfluidic chip. Herein, we introduce a monolithic acoustic droplet centrifuge module featuring nine miniaturized units, which enables the efficient enrichment of tumor cells and trace biomarkers within droplet arrays. This design not only streamlines multiple steps in miRNA detection processes but also significantly enhances analytical sensitivity. Such an innovative spiral surface acoustic wave array (SAWA) incorporates a space‐efficient architecture that maximizes channel density on miniaturized substrates, enabling parallel high‐throughput processing for particle/cell enrichment/separation and droplet centrifugation. We demonstrate that a single SAWA activation signal synchronized the multiple droplets control, enabling simultaneous centrifugation and detection processes of up to nine droplets on a 13 cm 2 chip. Compared to the routine miRNA detection process using monodispersed particles, our SAWA‐based approach improves fluorescence signal sensitivity by enriching functionalized particles, achieving the limit of detection down to 10 −14 mol/L. Therefore, such SAWA platform offers significant potential to advance early cancer diagnostics.
Monolithic Acoustic Droplet Centrifuge Array for Enhancing Point‐of‐Care Detection of Trace MicroRNAs
MicroRNAs (miRNAs) are considered as critical biomarkers for early tumor diagnosis, yet conventional detection methods are limited in sample throughput, sensitivity, automation, and broader applicability. A promising approach for achieving a point‐of‐care detection platform involves the integration of physical pretreatment and biological sensing within a single microfluidic chip. Herein, we introduce a monolithic acoustic droplet centrifuge module featuring nine miniaturized units, which enables the efficient enrichment of tumor cells and trace biomarkers within droplet arrays. This design not only streamlines multiple steps in miRNA detection processes but also significantly enhances analytical sensitivity. Such an innovative spiral surface acoustic wave array (SAWA) incorporates a space‐efficient architecture that maximizes channel density on miniaturized substrates, enabling parallel high‐throughput processing for particle/cell enrichment/separation and droplet centrifugation. We demonstrate that a single SAWA activation signal synchronized the multiple droplets control, enabling simultaneous centrifugation and detection processes of up to nine droplets on a 13 cm 2 chip. Compared to the routine miRNA detection process using monodispersed particles, our SAWA‐based approach improves fluorescence signal sensitivity by enriching functionalized particles, achieving the limit of detection down to 10 −14 mol/L. Therefore, such SAWA platform offers significant potential to advance early cancer diagnostics.
- 20 January 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 261, 115461
A dual-modal GSH depletion and NIR-triggered nanoplatform for cascade-amplified phototherapy
- 20 January 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 261, 115461
A dual-modal GSH depletion and NIR-triggered nanoplatform for cascade-amplified phototherapy
- 10 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (24) , 12854-12864
High-Output Droplet Electricity Generator for Intelligent Self-Powered Biochemical Analysis
The detection and analysis of chemical and biological substances are crucial in fields such as pharmaceuticals, disease diagnosis food safety and environmental monitoring. However, traditional analytical methods often involve complex procedures, expensive equipment, and time-consuming processes, making it challenging to achieve high sensitivity, reliability, portability, and real-time detection. To overcome these challenges, we propose a miniaturized intelligent self-powered e-tongue (MISET) that introduces key innovations in liquid sensing technology. MISET features a confined liquid sensing environment, which significantly enhances signal stability by minimizing external interference and eliminating issues related to uncontrolled liquid-solid contact angles. Furthermore, it integrates a droplet energy generation (DEG) mechanism, transforming conventional interface-limited charge transfer into a bulk effect, thereby greatly improving charge transfer efficiency and boosting output signal intensity. This advancement not only enhances detection sensitivity but also substantially lowers the detection limit. Additionally, MISET leverages deep learning-assisted analysis to optimize signal processing and pattern recognition, further improving its accuracy and reliability. By addressing the limitations of existing electronic tongue systems, MISET represents a breakthrough in self-powered liquid sensing, offering a more stable, sensitive, and efficient approach for chemical and biological analysis.
- 10 June 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (24) , 12854-12864
High-Output Droplet Electricity Generator for Intelligent Self-Powered Biochemical Analysis
The detection and analysis of chemical and biological substances are crucial in fields such as pharmaceuticals, disease diagnosis food safety and environmental monitoring. However, traditional analytical methods often involve complex procedures, expensive equipment, and time-consuming processes, making it challenging to achieve high sensitivity, reliability, portability, and real-time detection. To overcome these challenges, we propose a miniaturized intelligent self-powered e-tongue (MISET) that introduces key innovations in liquid sensing technology. MISET features a confined liquid sensing environment, which significantly enhances signal stability by minimizing external interference and eliminating issues related to uncontrolled liquid-solid contact angles. Furthermore, it integrates a droplet energy generation (DEG) mechanism, transforming conventional interface-limited charge transfer into a bulk effect, thereby greatly improving charge transfer efficiency and boosting output signal intensity. This advancement not only enhances detection sensitivity but also substantially lowers the detection limit. Additionally, MISET leverages deep learning-assisted analysis to optimize signal processing and pattern recognition, further improving its accuracy and reliability. By addressing the limitations of existing electronic tongue systems, MISET represents a breakthrough in self-powered liquid sensing, offering a more stable, sensitive, and efficient approach for chemical and biological analysis.
- Open Access
- 11 May 2025
- Published by Wiley in Advanced Science
- Vol. 12 (28) , e2506746
Development of a DNA Aptamer‐Based Approach to Noninvasively Image CAR‐T Cells In Vivo and Traceless Enrichment In Vitro
Chimeric antigen receptor (CAR) T cells offered a potential cure for malignancies, however, their outcomes and dynamics across different anatomical sites remained inadequately characterized. Monitoring the bio‐distribution and tumor‐homing of CAR‐T cells in vivo is crucial, as it provides patient‐specific data that might inform on treatment success, potential failure, and off‐target toxicities. Herein, an Aptamer A3 by Cell‐SELEX (systematic evolution of ligands by exponential enrichment) is generated, which can bind with CAR‐T cells with nanomolar affinity. After CAR‐T cells are injected into Nalm6 xenograft tumor model mice through tail vein, Cy5‐labeled A3 is injected into mice for fluorescence time‐delay imaging in vivo. The fluorescence signal produced by the Cy5‐labeled A3 is accumulated in the tumor area and reached its maximum at day 14. Moreover, A3 could enrich CAR‐T cells in mixed cell populations in a traceless way. A3 is screened for CAR‐T cells imaging and CAR‐T cells enrichment, which may provide assistance for the evaluation of CAR‐T cells efficacy and the manufacture of CAR‐T cells. Overall, this research shows that A3 enabled repeated, sensitive, and specific assessment of the infused CAR‐T cells in vivo. The screened aptamer will have broad applications for tracking CAR‐T cells in patients, providing insights into treatment success, potential failure, and off‐target toxicities.
- 11 May 2025
- Published by Wiley in Advanced Science
- Vol. 12 (28) , e2506746
Open AccessDevelopment of a DNA Aptamer‐Based Approach to Noninvasively Image CAR‐T Cells In Vivo and Traceless Enrichment In Vitro
Chimeric antigen receptor (CAR) T cells offered a potential cure for malignancies, however, their outcomes and dynamics across different anatomical sites remained inadequately characterized. Monitoring the bio‐distribution and tumor‐homing of CAR‐T cells in vivo is crucial, as it provides patient‐specific data that might inform on treatment success, potential failure, and off‐target toxicities. Herein, an Aptamer A3 by Cell‐SELEX (systematic evolution of ligands by exponential enrichment) is generated, which can bind with CAR‐T cells with nanomolar affinity. After CAR‐T cells are injected into Nalm6 xenograft tumor model mice through tail vein, Cy5‐labeled A3 is injected into mice for fluorescence time‐delay imaging in vivo. The fluorescence signal produced by the Cy5‐labeled A3 is accumulated in the tumor area and reached its maximum at day 14. Moreover, A3 could enrich CAR‐T cells in mixed cell populations in a traceless way. A3 is screened for CAR‐T cells imaging and CAR‐T cells enrichment, which may provide assistance for the evaluation of CAR‐T cells efficacy and the manufacture of CAR‐T cells. Overall, this research shows that A3 enabled repeated, sensitive, and specific assessment of the infused CAR‐T cells in vivo. The screened aptamer will have broad applications for tracking CAR‐T cells in patients, providing insights into treatment success, potential failure, and off‐target toxicities.
- 22 April 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 282, 117505
Reconfigurable acoustic tweezer for precise tracking and in-situ sensing of trace miRNAs in tumor cells
- 22 April 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 282, 117505
Reconfigurable acoustic tweezer for precise tracking and in-situ sensing of trace miRNAs in tumor cells
- 5 February 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (2) , 1155-1165
Urease-Driven Janus Nanomotors for Dynamic Enrichment and Multiplexed Detection of Bladder Cancer MicroRNAs in Urine
Bladder cancer diagnosis typically involves approaches such as cystoscopy, biopsy, urine cytology, and medical imaging. However, these invasive procedures carry a risk of complications, and direct in vitro detection on clinical samples often results in low sensitivity. Therefore, this study proposed urease-driven magnetic nanomotors for the simultaneous detection of bladder cancer biomarkers miRNA-21 and miRNA-182 in urine samples, aiming for noninvasive diagnosis. The nanomotor was constructed from gold nanorods, mesoporous organo-silica, Fe3O4, and hairpin DNA (hDNA), functioning as a recognition probe for the target miRNAs. In the urea solution, urease catalyzed urea into ammonia and carbon dioxide, propelling the nanomotor for about 60 min, which enhanced the capacity of the probes to capture the target miRNAs. Subsequently, magnetic enrichment enabled highly sensitive dual-miRNA analysis, allowing quantification of miRNA-21 and miRNA-182 with detection limits of 29 and 362 fM, respectively. The nanoprobes also effectively detected miRNAs in spiked urine samples. This simultaneous detection of multiple miRNAs increased the reliability of cancer diagnosis, presenting a novel noninvasive strategy for bladder cancer detection through precise in vitro analysis of actual urine samples.
- 5 February 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (2) , 1155-1165
Urease-Driven Janus Nanomotors for Dynamic Enrichment and Multiplexed Detection of Bladder Cancer MicroRNAs in Urine
Bladder cancer diagnosis typically involves approaches such as cystoscopy, biopsy, urine cytology, and medical imaging. However, these invasive procedures carry a risk of complications, and direct in vitro detection on clinical samples often results in low sensitivity. Therefore, this study proposed urease-driven magnetic nanomotors for the simultaneous detection of bladder cancer biomarkers miRNA-21 and miRNA-182 in urine samples, aiming for noninvasive diagnosis. The nanomotor was constructed from gold nanorods, mesoporous organo-silica, Fe3O4, and hairpin DNA (hDNA), functioning as a recognition probe for the target miRNAs. In the urea solution, urease catalyzed urea into ammonia and carbon dioxide, propelling the nanomotor for about 60 min, which enhanced the capacity of the probes to capture the target miRNAs. Subsequently, magnetic enrichment enabled highly sensitive dual-miRNA analysis, allowing quantification of miRNA-21 and miRNA-182 with detection limits of 29 and 362 fM, respectively. The nanoprobes also effectively detected miRNAs in spiked urine samples. This simultaneous detection of multiple miRNAs increased the reliability of cancer diagnosis, presenting a novel noninvasive strategy for bladder cancer detection through precise in vitro analysis of actual urine samples.
- Open Access
- 1 December 2024
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 107 (12) , 10328-10339
High catalytic nickel-platinum nanozyme enhancing colorimetric detection of Salmonella Typhimurium in milk
Colorimetric qualitative and sensitive quantitative detection of Salmonella Typhimurium (S. Typhimurium) holds significant importance for ensuring food safety and preventing foodborne illnesses. In the study, an ultra-high catalytic activity and biocompatible nickel-platinum nanoparticle (NiPt NP) nanozyme is successful synthesized to prepare a NLISA strategy for the detection of S. Typhimurium. The synthesized NiPt NPs exhibit high oxidase-like catalytic efficiency, with a Michaelis constant (Km) of 0.493 mM, similar to that of natural horseradish peroxidase (HRP). The maximal reaction velocity (Vmax) was determined to be 1.97 × 10-7 M·s-1 exhibiting a 1.97-fold higher than that of the HRP (1.0 × 10-7 M·s-1). Meanwhile, the antibody employed in this NiPt NPs-based NLISA exhibits exceptional capture efficacy, generating a stable immune complex with S. Typhimurium. The NiPt NPs-based NLISA demonstrates sensitivity, specificity, convenience, and cost-efficiency for the detection of S. Typhimurium. Under optimal conditions, this NiPt NPs-based NLISA demonstrates a quantitative range of 103∼106 cfu/mL with a detection limit as low as 103 cfu/mL. A single-blind experimental testing detects different concentrations of S. Typhimurium spiked skim milk, indicating the application potential of the proposed NLISA in real samples. In all, this research provides novel insights into the synthesis of nanozymes with excellent catalytic activity and their applications in S. Typhimurium biosensing.
- 1 December 2024
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 107 (12) , 10328-10339
Open AccessHigh catalytic nickel-platinum nanozyme enhancing colorimetric detection of Salmonella Typhimurium in milk
Colorimetric qualitative and sensitive quantitative detection of Salmonella Typhimurium (S. Typhimurium) holds significant importance for ensuring food safety and preventing foodborne illnesses. In the study, an ultra-high catalytic activity and biocompatible nickel-platinum nanoparticle (NiPt NP) nanozyme is successful synthesized to prepare a NLISA strategy for the detection of S. Typhimurium. The synthesized NiPt NPs exhibit high oxidase-like catalytic efficiency, with a Michaelis constant (Km) of 0.493 mM, similar to that of natural horseradish peroxidase (HRP). The maximal reaction velocity (Vmax) was determined to be 1.97 × 10-7 M·s-1 exhibiting a 1.97-fold higher than that of the HRP (1.0 × 10-7 M·s-1). Meanwhile, the antibody employed in this NiPt NPs-based NLISA exhibits exceptional capture efficacy, generating a stable immune complex with S. Typhimurium. The NiPt NPs-based NLISA demonstrates sensitivity, specificity, convenience, and cost-efficiency for the detection of S. Typhimurium. Under optimal conditions, this NiPt NPs-based NLISA demonstrates a quantitative range of 103∼106 cfu/mL with a detection limit as low as 103 cfu/mL. A single-blind experimental testing detects different concentrations of S. Typhimurium spiked skim milk, indicating the application potential of the proposed NLISA in real samples. In all, this research provides novel insights into the synthesis of nanozymes with excellent catalytic activity and their applications in S. Typhimurium biosensing.
- Open Access
- 30 October 2024
- Published by Elsevier in Materials Today Bio
- Vol. 29, 101318
An intelligent poly aptamer-encoded DNA nanoclew for tumor site activated mitochondria-targeted photodynamic therapy and MR imaging
- 30 October 2024
- Published by Elsevier in Materials Today Bio
- Vol. 29, 101318
Open AccessAn intelligent poly aptamer-encoded DNA nanoclew for tumor site activated mitochondria-targeted photodynamic therapy and MR imaging
- 3 December 2023
- Published by Elsevier in Bioorganic Chemistry
- Vol. 143, 107014
Evaluation of a biomarker (NO) dynamics in inflammatory zebrafish and periodontitis saliva samples via a fast-response and sensitive fluorescent probe
- 3 December 2023
- Published by Elsevier in Bioorganic Chemistry
- Vol. 143, 107014
Evaluation of a biomarker (NO) dynamics in inflammatory zebrafish and periodontitis saliva samples via a fast-response and sensitive fluorescent probe